An economic and regulatory affairs analyst, Joel Alalade, has warned that proposed amendments to the National Agency for Food and Drug Administration and Control (NAFDAC) Act could create overlapping regulatory responsibilities, increase business costs and undermine Nigeria’s ease of doing business.
Alalade raised the concerns while reacting to the public hearing on Senate Bill 952 (SB 952) at the National Assembly, describing some provisions of the proposed legislation as capable of creating confusion and complications for businesses.
He acknowledged the importance of strengthening regulatory institutions to protect public health and consumer safety but argued that legislative reforms should promote clear responsibilities and cooperation among government agencies.
According to him, empowering multiple agencies to perform similar functions could increase compliance costs and create uncertainty for businesses.
“The objective of regulation should be to provide certainty and confidence for businesses, investors, and consumers. However, where multiple agencies are empowered to perform similar functions, the result can be regulatory confusion, increased cost of compliance, and uncertainty for operators,” he said.
Alalade identified tobacco product control, enforcement and monitoring as areas where the proposed amendments could overlap with existing regulatory frameworks.
He argued that Nigeria already has legislation and institutions responsible for tobacco regulation, warning that additional layers of authority without clearly defined boundaries could weaken enforcement and create duplication.
The analyst also said regulatory uncertainty could discourage investment, affect production planning and undermine efforts to expand local manufacturing.
He urged lawmakers to adopt international best practices by ensuring that regulatory agencies operate within clearly defined mandates while maintaining effective collaboration.
“Public health protection and economic growth are not mutually exclusive. The challenge is to create regulations that protect citizens while maintaining a transparent, coordinated, and investment-friendly environment,” he added.
Zebra News reports that Alalade called for wider stakeholder consultation and a careful assessment of the proposed bill’s economic, regulatory and institutional implications before its passage.
He urged the National Assembly to ensure that the legislation strengthens Nigeria’s regulatory system rather than creating unnecessary barriers for legitimate businesses.
The proposed Food, Medical Products and Other Regulated Products Act 2026, listed as Senate Bill 952, has passed second reading and been referred to the Senate Committee on Health, chaired by Senator Banigo, for further consideration.

